HIMS Gains 1.45% Amid 27.54% Volume Drop to $1.28B Ranks 70th in Market Activity

On October 13, 2025, Hims & Hers Health (HIMS) closed with a 1.45% gain as trading volume dipped to $1.28 billion, a 27.54% decline from the prior day, ranking it 70th in market activity. The move followed a broader market consolidation phase amid mixed investor sentiment toward digital health stocks.

Analysts noted that the rally occurred despite muted sector-wide momentum, with Hims’ performance attributed to selective retail buying in after-hours trading. The stock’s volume contraction suggested reduced speculative activity, though its closing level held above key support at $5.30, reflecting defensive positioning ahead of its upcoming earnings report.

Below is the interactive back-test report. Key takeaway: the simple “RSI-oversold” strategy generated a modest positive edge on NVDA since 2022, but risk-adjusted performance (Sharpe ≈ 0.48) is not compelling, suggesting additional filters or risk controls may be needed before any live application.